Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Nucleic Acids Research|May 24, 2011
A rapid, inexpensive yeast-based dual-fluorescence assay of programmed--1 ribosomal frameshifting for high-throughput screeningRasa Rakauskaite, Pei-Yu Liao, Michael H J Rhodin, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1997
Ultrastructure changes associated with brain death in the human donor heartD Novitzky, J Rhodin, D K Cooper, et al.
The Journal of Infectious Diseases|October 23, 2024
EDP-938 Has a High Barrier to Resistance in Healthy Adults Experimentally Infected with Respiratory Syncytial VirusRachel Emily Levene, John DeVincenzo, Annie L Conery, et al.
Molecular Ecology|February 19, 2009
Unexpected early extinction of the European pond turtle (Emys orbicularis) in Sweden and climatic impact on its Holocene rangeRobert S Sommer, Charlotte Lindqvist, Arne Persson, et al.
Evolution; International Journal of Organic Evolution|March 20, 2003
Molecular systematics, phylogeography, and the effects of Pleistocene glaciation in the painted turtle (Chrysemys picta) complexDavid E Starkey, H Bradley Shaffer, Russell L Burke, et al.
Antimicrobial Agents and Chemotherapy|August 10, 2016
Preclinical and Clinical Resistance Profile of EDP-239, a Novel Hepatitis C Virus NS5A InhibitorChristopher M Owens, Bradley B Brasher, Alex Polemeropoulos, et al.
Plos Pathogens|March 15, 2021
EDP-938, a novel nucleoprotein inhibitor of respiratory syncytial virus, demonstrates potent antiviral activities in vitro and in a non-human primate modelMichael H J Rhodin, Nicole V McAllister, Jonathan Castillo, et al.
Current Biology : CB|May 20, 2015
The importance and benefits of speciesClaude Gascon, Thomas M Brooks, Topiltzin Contreras-MacBeath, et al.
Antimicrobial Agents and Chemotherapy|August 10, 2016
Preclinical Profile and Clinical Efficacy of a Novel Hepatitis C Virus NS5A Inhibitor, EDP-239Christopher M Owens, Bradley B Brasher, Alex Polemeropoulos, et al.
Nature Communications|August 1, 2024
The small molecule inhibitor of SARS-CoV-2 3CLpro EDP-235 prevents viral replication and transmission in vivoMichael H J Rhodin, Archie C Reyes, Anand Balakrishnan, et al.
Pageof 3